Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes": a Randomized Open-label Study

NCT05305794 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT05305794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05305794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes": a Randomized Open-label Study
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Phase 3
Overall status
Recruiting
Start date
July 12, 2022
Completion date
August 31, 2028
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

double diabetes